Question 1

What are the potential benefits of using [18F]FPyQCP for my specific type of cancer?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the [18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications clinical trial (NCT07432633). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this imaging compare to other standard imaging methods I might have?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the [18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications clinical trial (NCT07432633). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the possible side effects or risks associated with this imaging agent?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the [18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications clinical trial (NCT07432633). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for imaging or follow-up visits during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the [18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications clinical trial (NCT07432633). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the [18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications clinical trial (NCT07432633). Contact the study team or your healthcare provider for specific answers.

Question 6

Will my insurance cover the costs associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the [18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications clinical trial (NCT07432633). Contact the study team or your healthcare provider for specific answers.

What this study is about